PharmaCyte Biotech (PMCB) Accounts Payables (2011 - 2026)
PharmaCyte Biotech's Accounts Payables was $390,535 in fiscal Q1 2027 (quarter ended Jul 31, 2026), down 16.1% from $465,209 a year earlier but up 44.1% from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Accounts Payables (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), Accounts Payables at PharmaCyte Biotech came in at $271,102, down 32.1% from FY2025.
- Accounts Payables shows a five-year compound annual growth rate of 9.5% (FY2021 to FY2026).
- In earlier fiscal years, Accounts Payables was $399,204 in FY2025 (-45.7%), $735,199 in FY2024 (+473.1%), $128,281 in FY2023 (-37.5%) and $205,361 in FY2022 (+19.2%).
- Quarterly Accounts Payables has moved between $92,861 (fiscal Q3 2022) and $1.2 million (fiscal Q3 2026) over five years.
- Compared with a year earlier, Accounts Payables was higher in four of the last eight quarters, with growth averaging 50.9%.
- The best year-over-year quarter for Accounts Payables over five years was fiscal Q4 2024 (growth of 473.1%); the worst was fiscal Q2 2024 (a decline of 85.4%).
- Per Business Quant data, PMCB's Accounts Payables in the three fiscal quarters before Q1 2027 was $271,102 (Q4 2026), $1.2 million (Q3 2026) and $1.02 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | PharmaCyte Biotech | 4.40 Mn | 4.40 Mn | - | 390,535.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 390,535.00 |
| Apr 30, 2026 | 271,102.00 |
| Jan 31, 2026 | 1.20 Mn |
| Oct 31, 2025 | 1.02 Mn |
| Jul 31, 2025 | 465,209.00 |
| Apr 30, 2025 | 399,204.00 |
| Jan 31, 2025 | 484,948.00 |
| Oct 31, 2024 | 348,595.00 |
| Jul 31, 2024 | 553,952.00 |
| Apr 30, 2024 | 735,199.00 |
| Jan 31, 2024 | 484,198.00 |
| Oct 31, 2023 | 126,163.00 |
| Jul 31, 2023 | 718,130.00 |
| Apr 30, 2023 | 128,281.00 |
| Jan 31, 2023 | 445,935.00 |
| Oct 31, 2022 | 861,276.00 |
| Jul 31, 2022 | 559,026.00 |
| Apr 30, 2022 | 205,361.00 |
| Jan 31, 2022 | 92,861.00 |
| Oct 31, 2021 | 157,039.00 |
API Access
PharmaCyte Biotech Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();